Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

ClinicalTrials.gov ID: NCT01788046

Public ClinicalTrials.gov record NCT01788046. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis

Study identification

NCT ID
NCT01788046
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
515 participants

Conditions and interventions

Interventions

  • Etelcalcetide Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 11, 2013
Primary completion
Apr 13, 2014
Completion
May 8, 2014
Last update posted
Aug 19, 2019

2013 – 2014

United States locations

U.S. sites
45
U.S. states
25
U.S. cities
45
Facility City State ZIP Site status
Research Site Mobile Alabama 36608
Research Site Azusa California 91702
Research Site Beverly Hills California 90211
Research Site Chula Vista California 91910
Research Site Fairfield California 94534
Research Site Glendale California 91205
Research Site Los Angeles California 90022
Research Site Northridge California 91324
Research Site Norwalk California 90650
Research Site Riverside California 92501
Research Site Simi Valley California 93065
Research Site Denver Colorado 80230
Research Site Stamford Connecticut 06902
Research Site Lauderdale Lakes Florida 33313
Research Site Miami Florida 33173
Research Site Ocala Florida 34471
Research Site Augusta Georgia 30901
Research Site Macon Georgia 31217
Research Site Chicago Illinois 60616
Research Site Gurnee Illinois 60031
Research Site Merrillville Indiana 46410
Research Site Wichita Kansas 67214-2998
Research Site Shreveport Louisiana 71101
Research Site Bethesda Maryland 20817
Research Site Ft. Washington Maryland 20744
Research Site Detroit Michigan 48202
Research Site Brookhaven Mississippi 39601
Research Site Lincoln Nebraska 68510
Research Site Las Vegas Nevada 89106
Research Site Eatontown New Jersey 07724
Research Site Brooklyn New York 11212
Research Site Fresh Meadows New York 11365
Research Site Great Neck New York 11021
Research Site Charlotte North Carolina 28207
Research Site New Bern North Carolina 28562
Research Site Cincinnati Ohio 45206
Research Site Columbia South Carolina 29203
Research Site Chattanooga Tennessee 37408
Research Site Knoxville Tennessee 37923
Research Site Arlington Texas 76015
Research Site Houston Texas 77054
Research Site Lubbock Texas 79430
Research Site Rutland Vermont 05701
Research Site Alexandria Virginia 22304
Research Site Morgantown West Virginia 26506-9165

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01788046, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01788046 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →